Research ExplorerPublicationsManagement of pericardial tamponade in the electrophysiology...

Management of pericardial tamponade in the electrophysiology laboratory: results from a national survey

Standard

Management of pericardial tamponade in the electrophysiology laboratory: results from a national survey. / Metzner, Andreas; Reubold, Stephan D; Schönhofer, Sophie; Reißmann, Bruno; Ouyang, Feifan; Rottner, Laura; Schleberger, Ruben; Dinshaw, Leon; Moser, Julia; Moser, Fabian; Lemoine, Marc; Münkler, Paula; Kany, Shinwan; Steven, Daniel; Sommer, Philipp; Kirchhof, Paulus; Rillig, Andreas.

In: CLIN RES CARDIOL, Vol. 112, No. 12, 12.2023, p. 1727-1737.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Metzner, A, Reubold, SD, Schönhofer, S, Reißmann, B, Ouyang, F, Rottner, L, Schleberger, R, Dinshaw, L, Moser, J, Moser, F, Lemoine, M, Münkler, P, Kany, S, Steven, D, Sommer, P, Kirchhof, P & Rillig, A 2023, 'Management of pericardial tamponade in the electrophysiology laboratory: results from a national survey', CLIN RES CARDIOL, vol. 112, no. 12, pp. 1727-1737. https://doi.org/10.1007/s00392-022-02042-x

APA

Metzner, A., Reubold, S. D., Schönhofer, S., Reißmann, B., Ouyang, F., Rottner, L., Schleberger, R., Dinshaw, L., Moser, J., Moser, F., Lemoine, M., Münkler, P., Kany, S., Steven, D., Sommer, P., Kirchhof, P., & Rillig, A. (2023). Management of pericardial tamponade in the electrophysiology laboratory: results from a national survey. CLIN RES CARDIOL, 112(12), 1727-1737. https://doi.org/10.1007/s00392-022-02042-x

Vancouver

Metzner A, Reubold SD, Schönhofer S, Reißmann B, Ouyang F, Rottner L et al. Management of pericardial tamponade in the electrophysiology laboratory: results from a national survey. CLIN RES CARDIOL. 2023 Dec;112(12):1727-1737. https://doi.org/10.1007/s00392-022-02042-x

Bibtex

@article{fa01f8fb50d74a86b7047eaebb2a6e47,
title = "Management of pericardial tamponade in the electrophysiology laboratory: results from a national survey",
abstract = "BACKGROUND: Despite continued efforts to improve the safety of catheter ablation, pericardial tamponade remains one of its more frequent, potentially life-threatening complications. Management of cardiac tamponade is not standardized and uncertainties regarding acute treatment remain.METHODS: This survey sought to evaluate the management of cardiac tamponade in German EP centers via a standardized postal questionnaire. All 341 identified German EP centers were invited to return a questionnaire on their standards for the management of cardiac tamponade.RESULTS: A total of 189 German EP centers completed the questionnaire. Several precautions are followed to avoid pericardial tamponade: A minority of centers preclude very old patients (19%) or those with a high body mass index (30%) from ablation. Non-vitamin K antagonist oral anticoagulants are briefly paused in most centers (88%) before procedures, while vitamin K antagonists are continued. Pericardial tamponade is usually treated using reversal of heparin by applying protamine (86%) and pericardiocentesis under both, fluoroscopic and echocardiographic guidance (62%). A pigtail catheter is mostly inserted (97%) and autotransfusion of aspirated blood is performed in 47% of centers. The decision for surgical repair depends on different clinical and infrastructural aspects. The timing of reinitiation of anticoagulation widely differs between the centers. Approximately 1/3 of centers prescribe nonsteroidal anti-inflammatory agents, colchicine or steroids after pericardiocentesis.CONCLUSION: The present survey shows that the management of cardiac tamponade is still inhomogeneous in German ablation centers. However, multiple findings of this survey can be generalized and might guide especially less experienced operators and centers in their treatment and decision strategies.",
author = "Andreas Metzner and Reubold, {Stephan D} and Sophie Sch{\"o}nhofer and Bruno Rei{\ss}mann and Feifan Ouyang and Laura Rottner and Ruben Schleberger and Leon Dinshaw and Julia Moser and Fabian Moser and Marc Lemoine and Paula M{\"u}nkler and Shinwan Kany and Daniel Steven and Philipp Sommer and Paulus Kirchhof and Andreas Rillig",
note = "{\textcopyright} 2022. The Author(s).",
year = "2023",
month = dec,
doi = "10.1007/s00392-022-02042-x",
language = "English",
volume = "112",
pages = "1727--1737",
journal = "CLIN RES CARDIOL",
issn = "1861-0684",
publisher = "D. Steinkopff-Verlag",
number = "12",

}

RIS

TY - JOUR

T1 - Management of pericardial tamponade in the electrophysiology laboratory: results from a national survey

AU - Metzner, Andreas

AU - Reubold, Stephan D

AU - Schönhofer, Sophie

AU - Reißmann, Bruno

AU - Ouyang, Feifan

AU - Rottner, Laura

AU - Schleberger, Ruben

AU - Dinshaw, Leon

AU - Moser, Julia

AU - Moser, Fabian

AU - Lemoine, Marc

AU - Münkler, Paula

AU - Kany, Shinwan

AU - Steven, Daniel

AU - Sommer, Philipp

AU - Kirchhof, Paulus

AU - Rillig, Andreas

N1 - © 2022. The Author(s).

PY - 2023/12

Y1 - 2023/12

N2 - BACKGROUND: Despite continued efforts to improve the safety of catheter ablation, pericardial tamponade remains one of its more frequent, potentially life-threatening complications. Management of cardiac tamponade is not standardized and uncertainties regarding acute treatment remain.METHODS: This survey sought to evaluate the management of cardiac tamponade in German EP centers via a standardized postal questionnaire. All 341 identified German EP centers were invited to return a questionnaire on their standards for the management of cardiac tamponade.RESULTS: A total of 189 German EP centers completed the questionnaire. Several precautions are followed to avoid pericardial tamponade: A minority of centers preclude very old patients (19%) or those with a high body mass index (30%) from ablation. Non-vitamin K antagonist oral anticoagulants are briefly paused in most centers (88%) before procedures, while vitamin K antagonists are continued. Pericardial tamponade is usually treated using reversal of heparin by applying protamine (86%) and pericardiocentesis under both, fluoroscopic and echocardiographic guidance (62%). A pigtail catheter is mostly inserted (97%) and autotransfusion of aspirated blood is performed in 47% of centers. The decision for surgical repair depends on different clinical and infrastructural aspects. The timing of reinitiation of anticoagulation widely differs between the centers. Approximately 1/3 of centers prescribe nonsteroidal anti-inflammatory agents, colchicine or steroids after pericardiocentesis.CONCLUSION: The present survey shows that the management of cardiac tamponade is still inhomogeneous in German ablation centers. However, multiple findings of this survey can be generalized and might guide especially less experienced operators and centers in their treatment and decision strategies.

AB - BACKGROUND: Despite continued efforts to improve the safety of catheter ablation, pericardial tamponade remains one of its more frequent, potentially life-threatening complications. Management of cardiac tamponade is not standardized and uncertainties regarding acute treatment remain.METHODS: This survey sought to evaluate the management of cardiac tamponade in German EP centers via a standardized postal questionnaire. All 341 identified German EP centers were invited to return a questionnaire on their standards for the management of cardiac tamponade.RESULTS: A total of 189 German EP centers completed the questionnaire. Several precautions are followed to avoid pericardial tamponade: A minority of centers preclude very old patients (19%) or those with a high body mass index (30%) from ablation. Non-vitamin K antagonist oral anticoagulants are briefly paused in most centers (88%) before procedures, while vitamin K antagonists are continued. Pericardial tamponade is usually treated using reversal of heparin by applying protamine (86%) and pericardiocentesis under both, fluoroscopic and echocardiographic guidance (62%). A pigtail catheter is mostly inserted (97%) and autotransfusion of aspirated blood is performed in 47% of centers. The decision for surgical repair depends on different clinical and infrastructural aspects. The timing of reinitiation of anticoagulation widely differs between the centers. Approximately 1/3 of centers prescribe nonsteroidal anti-inflammatory agents, colchicine or steroids after pericardiocentesis.CONCLUSION: The present survey shows that the management of cardiac tamponade is still inhomogeneous in German ablation centers. However, multiple findings of this survey can be generalized and might guide especially less experienced operators and centers in their treatment and decision strategies.

U2 - 10.1007/s00392-022-02042-x

DO - 10.1007/s00392-022-02042-x

M3 - SCORING: Journal article

C2 - 35713695

VL - 112

SP - 1727

EP - 1737

JO - CLIN RES CARDIOL

JF - CLIN RES CARDIOL

SN - 1861-0684

IS - 12

ER -